[1] BHATT S P, BALTE P P, SCHWARTZ J E, et al. Discriminative accuracy of FEV1:FVC thresholds for COPD-related hospitalization and mortality[J]. JAMA, 2019, 321(24):2438-2447. [2] 陈亚红.2020年GOLD慢性阻塞性肺疾病诊断、治疗及预防全球策略解读[J].中国医学前沿杂志:电子版,2019,11(12):32-50. [3] 潘子涵,迟春花,郑家强.基层医疗机构慢性阻塞性肺疾病筛查方法研究现状[J].中国全科医学,2020,23(3):257-266. [4] SICHLETIDIS L, SPAYRATOS D, PAPAIOANNOU M, et al.A combination of the IPAG questionnaire and PiKo-6 flow meter is a valuable screening tool for COPD in the primary care setting[J].Prim Care Respir J,2011,20(2):184-189. [5] 秦国双,温昊于,宇传华.中国COPD的患病发病及YLD 现状及趋势[J].公共卫生与预防医学,2019,30(2):4-8. [6] PRICE D B, TINKELMAN D G, HALBERT R J,et al. Symptom-based questionnaire for identifying COPD in smokers[J]. Respiration,2006,73(3):285-295. [7] SUN L, CHEN Y, RUI W U,et al. Changes in definition lead to changes in the clinical characteristics across COPD categories according to GOLD 2017: a national cross-sectional survey in China[J]. Int J Chronic Obstr,2017,12:3095-3102. [8] CHAN K Y, LI X, CHEN W, et al. Prevalence of chronic obstructive pulmonary disease (COPD) in China in 1990 and 2010[J]. J Glob Health,2017,7(2):020704. [9] 胡国平,钟南山,冉丕鑫.中国的大气污染和COPD[J].中国胸心血管外科临床杂志,2016,23(2):107-112. [10] SCHAUER G L, WHEATON A G, MALARCHER A M,et al. Smoking prevalence and cessation characteristics among U.S. adults with and without COPD: findings from the 2011 Behavioral Risk Factor Surveillance System[J].COPD,2014,11(6):697-704. [11] 中华医学会.慢性阻塞性肺疾病基层诊疗指南(2018年)[J].中华全科医师杂志,2018,17(11):856-870. [12] 葛妍麟,陈红,杨嫦娟.基于症状的慢性阻塞性肺疾病筛查问卷在社区人群中的应用[J].当代护士,2014,11:124-125. |